Home-based auricular vagus nerve stimulation shows early promise for kids and teens with migraines
As clinicians and researchers, we often see how heavily migraine attacks weigh on children and adolescents, yet non-pharmacological, child-friendly treatment options remain strikingly scarce. For years, our team at Nanfang Hospital and collaborating institutes have been looking into ways to bridge this gap.
A recent study examining the use of home-based auricular vagus nerve stimulation for acute migraines in children and adolescents has shown promising results. Researchers from Nanfang Hospital and collaborating institutes sought to explore a non-pharmacological, child-friendly treatment option, specifically transcutaneous auricular vagus nerve stimulation (taVNS).
The vagus nerve, a major highway connecting the brain to internal organs, plays a crucial role in regulating involuntary functions like heart rate and digestion. During a migraine episode, central pain processing and autonomic regulation can become disrupted. TaVNS involves delivering mild electrical pulses to the auricular branch of the vagus nerve, potentially modulating autonomic activity and activating central pain-inhibitory pathways in the brain.
In this prospective, single-arm exploratory study published in Neuromodulation: Technology at the Neural Interface, 11 pediatric and adolescent patients (ages 7 to 18) self-administered 30-minute taVNS sessions at home over a 4-week period, tracking 72 treated migraine attacks. The approach proved to be highly feasible and well-tolerated, with only two mild, transient local skin reactions reported out of 72 treatment sessions.
Furthermore, 36.11% of the treated episodes resulted in medication-free 2-hour pain freedom. While these findings demonstrate the safety and feasibility of home-based neuromodulation in children and families, the lack of a control group limits conclusions about the efficacy of taVNS. The study builds upon previous work establishing a rigorous methodological and technical framework for auricular vagus nerve stimulation and directly complements clinical observations in pediatric chronic migraine cases.
However, due to the open-label, single-arm design and potential influence of psychological factors, the results should be interpreted with caution. Despite these limitations, the findings pave the way for an adequately powered, sham-controlled randomized trial, bringing us closer to offering young migraine sufferers a validated, non-drug therapeutic tool.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.